ITRM: Iterum Therapeutics plc Stock

by  •  • Comments Off on ITRM: Iterum Therapeutics plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.99
Enterprise Value ($M) 38.88
Book Value ($M) -6.40
Book Value / Share -0.39
Price / Book -4.06
NCAV ($M) -7.07
NCAV / Share -0.43
Price / NCAV -3.68

Profitability (mra)
Return on Invested Capital (ROIC) -2.93
Return on Assets (ROA) -0.66
Return on Equity (ROE) -2.02

Liquidity (mrq)
Quick Ratio 1.89
Current Ratio 1.89

Balance Sheet (mrq) ($M)
Current Assets 25.60
Assets 26.26
Liabilities 32.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -47.47
Net Income -38.37
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -39.33
Cash from Investing 23.34
Cash from Financing 1.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-31 13G Point72 Asset Management, L.P. 6.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 8,716 46,742 18.65
2024-05-02 16,219 140,282 11.56
2024-05-01 42,669 57,583 74.10
2024-04-30 54,401 24,828 219.11

(click for more detail)

Similar Companies
INM – InMed Pharmaceuticals Inc. INMB – INmune Bio, Inc.
INTS – Intensity Therapeutics, Inc. JAGX – Jaguar Health, Inc.
JAN – JanOne Inc.


Financial data and stock pages provided by
Fintel.io